Back to results
US 2022/0024851 A1Published application
Crystalline forms of multicyclic compounds and uses thereof
AssigneeConvelo Therapeutics, Inc.
InventorsBradley T. Lang, Emily M. Rigsbee, Ekaterina V. Albert
Life of this patent
Estimating the term…
Abstract
The invention is directed at esylate and salicylate salts of cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop-2-enylamine and their pharmaceutical composition. The invention is also directed at the use esylate and salicylate salts of cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-yclohexylphenyl)prop-2-enylamine and their pharmaceutical composition in treatment of myelin-related disorders.
Claims67
A solid form of the compound represented by formula (II):
A solid form of the compound of formula (III):
Dependencies are inferred from the claim text.